In a series of posts and questions for creating new approaches for treating and possibly curing HIV, I, Reginald B. Little (RBL), have considered the proposal by RBL in archive 2018 and published book in 2022 that hiv fractionates stable isotopes during its infection and development into AIDS to propose various new techniques that take advantage of such isotope fractionation to treat HIV { On the Atomic Carcinogenic Mechanism and Cure for Cancer: Ferrochemistry for Cause of Warburg Effect | On the Atomic Carcinogenic Mechanism and Cure for Cancer: Ferrochemistry for Cause of Warburg Effect }. The subsequent measurement of hiv enriching in 64Zn during infection of cells was published in 2023 by Guillin et al. { Zinc Uptake by HIV-1 Viral Particles: An Isotopic Study }. On the basis of such 64Zn enrichment in hiv and cells enriched in hiv, here I RBL propose use of X-rays for selectively stimulating 64Zn naturally intrinisically enriched in hiv and hiv infected cells for treating hiv. One of the powers of such approach is the permeability of the human body to X-rays and the ability of reaching all hidden hiv reservoirs in the human body. It could be that the synchrotron X-Rays may tune specifically to 64Zn in zinc finger proteins in hiv based on the uniques high zinc concentrations and also selective Cu--S complexes in hiv for selectively energizing hiv and hiv infected cells for killing hiv infected cells and mutating hiv in the cells throughout the body. Such damage of hiv infected cells may also trigger an immune response. The unique Zn2+ and Cu2+ protein structures and their high activities in hiv infected cells compared to normal none hiv infected cells may allow selective X-Ray stimulating the hiv infected cells. The selective X-Ray absorption of 64Zn in the hiv can result in scintillation by light emission from 64Zn in the hiv and hiv infected cells to damage the hiv and kill hiv infected cells. Here I (RBL) further propose the possibility of using selective UV radiation absorption to treat the blood of hiv infected individual based on the selective absorbance of Zn-S and Zn-O and Cu-S and Cu-O structures for inactivating hiv in infected cells rather than stem cell transplants. - Reginald B Little (April 9, 2025)